AUG 25, 2015 1:31 PM PDT

E. coli Infections Thwarted By Flu Treatments

WRITTEN BY: Kara Marker
The "gut microbiome" refers to the trillions of bacteria that colonize our intestines. The normal metabolic functions of these bacteria play an infinite role in human digestion, disease etiology, and other actions that have countless impacts on human health. The diversity of the bacteria in the human microbiome is incredibly vast, and the study of these gut flora has been one of recent interest and growth in the field of microbiology (Nature). Incredibly, there are more bacterial cells in our bodies than human cells.

Our gut microbiome, when regulated correctly, helps us with digestion and other processes.
Escherichia coli is a well-known bacteria common in cases of food-poisoning, but it is also a normal contributor to the gut microbiota. Under normal conditions, the body regulates the amount of different bacteria colonies that thrive in the gut. Under a proper balance, E. coli can live in our intestines without causing disease. A recent study at the University of Zurich described what happens when the microbiota equilibrium is disturbed. Although sometimes unexplained, damage to the intestines can cause certain bacterial groups, like E. coli, to grow to larger numbers than usual and cause infection-related inflammation in the gut. Misuse of antibiotics is often a known cause of these type of intestinal infections. When normal, harmless gut microbiota is killed after an unnecessary or overboard dose of antibiotics, bacteria like E. coli are left without bacterial neighbors competing for space and nutrients. Then, E. coli colonies grow to even larger numbers and cause disease.  

The researchers from Zurich found that "overproduction of E. coli can be attributed to the availability of the carbohydrate sialic acid." Surprisingly, E. coli doesn't make the enzyme needed to utilize sialic acid, sialidase. The bacteria find sialidase to use when its produced by other intestinal bacteria.

It turns out that treatments developed to combat flu infections contain a sialidase inhibitor. So patients with a microbiota imbalance will less often suffer from E. coli infections when they're already being treated with a flu remedy, like Tamiflu. The researchers are excited about the "new therapeutic possibilities" that could be derived from the components of flu medicines. New treatments for inflammatory intestinal diseases could be developing very soon.

In the video below, listen and watch NPR explain further the relationship between a human and his/her microbiome. 



Source: University of Zurich Media Desk 


 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 19, 2020
Cardiology
Examining a Possible Link Between Atherosclerosis and Inflammation
NOV 19, 2020
Examining a Possible Link Between Atherosclerosis and Inflammation
The immune system’s primary duty is to protect the body from dangerous invaders. Many don’t know that it als ...
NOV 17, 2020
Cell & Molecular Biology
Chronic Inflammation Lowers Levels of Aging-Linked Molecule
NOV 17, 2020
Chronic Inflammation Lowers Levels of Aging-Linked Molecule
Over the years, the molecule nicotinamide adenine dinucleotide (NAD+) has gone from being a player in some biochemical p ...
NOV 28, 2020
Microbiology
Potential Treatment ID'ed for Emerging Viral Disease
NOV 28, 2020
Potential Treatment ID'ed for Emerging Viral Disease
A mosquito-borne virus called VEEV has been emerging in South America. It causes symptoms that make it difficult to dist ...
DEC 03, 2020
Immunology
Cytokine Storms Aren't to Blame for COVID Respiratory Failures
DEC 03, 2020
Cytokine Storms Aren't to Blame for COVID Respiratory Failures
Many of the life-threatening symptoms of COVID-19 have been pinned on “cytokine storms” — immune syste ...
NOV 30, 2020
Cell & Molecular Biology
Can a Scent Motivate Us to Exercise?
NOV 30, 2020
Can a Scent Motivate Us to Exercise?
People are always looking for new ways to get inspired to exercise. Now odor is being proposed as a motivational tool fo ...
DEC 01, 2020
Drug Discovery & Development
Breakthrough Drug Reduces Inflammation and Pain in Arthritis
DEC 01, 2020
Breakthrough Drug Reduces Inflammation and Pain in Arthritis
Researchers from the Universities of Oxford and Birmingham in the UK have found that otilimab can reduce infla ...
Loading Comments...